Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 75, Issue 1, Pages 253-259
Publisher
BMJ
Online
2014-08-28
DOI
10.1136/annrheumdis-2014-205566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract S1-6: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (BC)
- (2014) RS Finn et al. CANCER RESEARCH
- Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors
- (2014) C. Sekine et al. JOURNAL OF IMMUNOLOGY
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- Genetics of rheumatoid arthritis contributes to biology and drug discovery
- (2013) Yukinori Okada et al. NATURE
- Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study
- (2013) Anne C. Bay-Jensen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
- (2012) P. Emery RHEUMATOLOGY
- Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study
- (2012) M. Tada et al. RHEUMATOLOGY
- Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
- (2011) B. Haraoui et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Development of Novel Combination Therapies
- (2011) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- State-of-the-art: rheumatoid arthritis
- (2010) I. B. McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- PADI4 polymorphism predisposes male smokers to rheumatoid arthritis
- (2010) Y. Kochi et al. ANNALS OF THE RHEUMATIC DISEASES
- Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
- (2010) C. Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important
- (2009) Emeli Lundström et al. ARTHRITIS AND RHEUMATISM
- Are new agents needed to treat RA?
- (2009) Peter E. Lipsky Nature Reviews Rheumatology
- Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
- (2008) Clare A. Notley et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started